Literature DB >> 8360189

Functional characterization of the alternatively spliced, placental human growth hormone receptor.

M Urbanek1, J E Russell, N E Cooke, S A Liebhaber.   

Abstract

The human growth hormone family of peptide hormones is encoded by five genes, pituitary growth hormone (hGH-N), and four placentally expressed genes, growth hormone variant (hGH-V), chorionic somatomammotropin A and B (hCS-A, hCS-B), and prolactin (hPrl). As part of an effort to define the local effects of the placentally expressed members of the GH/Prl family of hormones on the placenta, we have identified an isoform (hGHRd3) of the growth hormone receptor expressed in the placental villi. hGHRd3 mRNA differs from the liver GHR mRNA by the deletion of a 66-base pair segment encoding exon 3. In this study we show that hGHRd3 mRNA encodes a stable and functional receptor. hGHRd3 mRNA is efficiently translated and processed in a rabbit reticulocyte lysate translation system as well as in an in vivo Xenopus laevis oocyte expression system. In Xenopus oocytes hGHRd3 is stably integrated into the cell membrane and binds and internalizes ligand as efficiently as hGHR. hGHRd3 binds all three of the placentally expressed members of the GH/Prl gene family (hGH-V, hCS, and Prl) as well as both the 22 and 20 kDa isoforms of the pituitary hGH-N. The results of the present study strongly support the expression of a functional hGHRd3 isoreceptor in the placenta which may serve in autocrine, paracrine, and/or endocrine activation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8360189

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

Review 1.  Maternal-placental-fetal interactions in the endocrine regulation of fetal growth: role of somatotrophic axes.

Authors:  Peter D Gluckman; Catherine S Pinal
Journal:  Endocrine       Date:  2002-10       Impact factor: 3.633

2.  Alternative splicing of exon 3 of the human growth hormone receptor is the result of an unusual genetic polymorphism.

Authors:  M L Stallings-Mann; R L Ludwiczak; K W Klinger; F Rottman
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

3.  Influence of growth hormone receptor (GHR) exon 3 and -202A/C IGFBP-3 genetic polymorphisms on clinical and biochemical features and therapeutic outcome of patients with acromegaly.

Authors:  Raquel S Jallad; Ericka B Trarbach; Felipe H Duarte; Alexander A L Jorge; Marcello D Bronstein
Journal:  Pituitary       Date:  2015-10       Impact factor: 4.107

Review 4.  The exon 3-deleted growth hormone receptor: molecular and functional characterization and impact on GH/IGF-I axis in physiological and pathological conditions.

Authors:  M Filopanti; C Giavoli; S Grottoli; A Bianchi; L De Marinis; E Ghigo; A Spada
Journal:  J Endocrinol Invest       Date:  2011-12       Impact factor: 4.256

Review 5.  Musculoskeletal Effects of Altered GH Action.

Authors:  Jonathan A Young; Shouan Zhu; Edward O List; Silvana Duran-Ortiz; Yosri Slama; Darlene E Berryman
Journal:  Front Physiol       Date:  2022-05-19       Impact factor: 4.755

Review 6.  Molecular mechanisms of prolactin and its receptor.

Authors:  Charles L Brooks
Journal:  Endocr Rev       Date:  2012-05-10       Impact factor: 19.871

Review 7.  Gastrointestinal effects of growth hormone.

Authors:  D I Shulman
Journal:  Endocrine       Date:  2000-04       Impact factor: 3.925

Review 8.  Treatment with Growth Hormone for Adults with Growth Hormone Deficiency Syndrome: Benefits and Risks.

Authors:  Juan J Díez; Susana Sangiao-Alvarellos; Fernando Cordido
Journal:  Int J Mol Sci       Date:  2018-03-17       Impact factor: 5.923

9.  Exon 3-deleted and full-length growth hormone receptor polymorphism frequencies in an Iranian population.

Authors:  A A Palizban; M Radmansorry; M Bozorgzad
Journal:  Res Pharm Sci       Date:  2014 Nov-Dec

10.  Frequency of the exon 3-deleted/full-length growth hormone receptor polymorphism in Saudi Arabian population.

Authors:  Yahia A Kaabi
Journal:  Saudi Med J       Date:  2017-11       Impact factor: 1.484

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.